Diego A. Pizzagalli

Active 1999–2025

237
Papers
38,756
Citations
97
h-index
221
i10-index

Citations

Citations per year for Diego A. Pizzagalli1974: 1 citations1975: 2 citations1976: 1 citations1978: 1 citations1979: 1 citations1980: 1 citations1981: 2 citations1986: 1 citations1990: 2 citations1992: 2 citations1993: 3 citations1994: 2 citations1995: 1 citations1997: 1 citations1999: 6 citations2000: 13 citations2001: 34 citations2002: 51 citations2003: 108 citations2004: 127 citations2005: 152 citations2006: 172 citations2007: 200 citations2008: 282 citations2009: 325 citations2010: 333 citations2011: 370 citations2012: 382 citations2013: 390 citations2014: 417 citations2015: 492 citations2016: 464 citations2017: 395 citations2018: 436 citations2019: 1,217 citations2020: 1,489 citations2021: 1,502 citations2022: 1,256 citations2023: 972 citations2024: 1,526 citations2025: 677 citations2026: 48 citations1977: no citations, so this year is not shown1982–1985: no citations, so these years are not shown1987–1989: no citations, so these years are not shown1991: no citations, so this year is not shown1996: no citations, so this year is not shown1998: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,562 citing papers, 31.6% of this breakdownChina: 1,553 citing papers, 10.7% of this breakdownUnited Kingdom: 1,083 citing papers, 7.5% of this breakdownGermany: 1,025 citing papers, 7.1% of this breakdownCanada: 786 citing papers, 5.4% of this breakdownNetherlands: 575 citing papers, 4% of this breakdownAustralia: 476 citing papers, 3.3% of this breakdownItaly: 396 citing papers, 2.7% of this breakdownSwitzerland: 384 citing papers, 2.7% of this breakdownFrance: 298 citing papers, 2.1% of this breakdownSpain: 253 citing papers, 1.7% of this breakdownJapan: 244 citing papers, 1.7% of this breakdown
0%31.6%Other 19.5%

Fields

  • Neuroscience52.8%
  • Psychology22%
  • Medicine16.7%
  • Biochemistry, Genetics and Molecular Biology2.4%
  • Computer Science1.9%
  • Social Sciences1%
  • Other3.2%

Topics

  • Functional Brain Connectivity Studies9.8%
  • Neural and Behavioral Psychology Studies7.5%
  • Mental Health Research Topics5.1%
  • Stress Responses and Cortisol4.4%
  • Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes3.6%
  • Neural dynamics and brain function3.4%
  • Other66.2%

Coauthors

All papers

Open in search
  1. Large-Scale Network Dysfunction in Major Depressive Disorder

    Authors: , , , - JAMA Psychiatry 2015 cited by 2,264

  2. Prefrontal cortex and depression

    Authors: , - Neuropsychopharmacology 2021 cited by 595

  3. The Impact of Stress and Major Depressive Disorder on Hippocampal and Medial Prefrontal Cortex Morphology

    Authors: , , - Biological Psychiatry 2018 cited by 545

  4. Handbook of Psychophysiology

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Cambridge University Press eBooks 2001 cited by 4,511

  5. An electroencephalographic signature predicts antidepressant response in major depression

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Biotechnology 2020 cited by 305

  6. Depression, Stress, and Anhedonia: Toward a Synthesis and Integrated Model

    Authors: - Annual Review of Clinical Psychology 2014 cited by 1,146

  7. Effects of early life stress on cognitive and affective function: an integrated review of human literature

    Authors: , - Psychopharmacology 2010 cited by 1,369

  8. Frontocingulate Dysfunction in Depression: Toward Biomarkers of Treatment Response

    Authors: - Neuropsychopharmacology 2010 cited by 943

  9. Toward a Better Understanding of the Mechanisms and Pathophysiology of Anhedonia: Are We Ready for Translation?

    Authors: - American Journal of Psychiatry 2022 cited by 182

  10. Reduced Caudate and Nucleus Accumbens Response to Rewards in Unmedicated Individuals With Major Depressive Disorder

    Authors: , , , , , , , , , - American Journal of Psychiatry 2009 cited by 1,254

  11. A randomized proof-of-mechanism trial applying the ‘fast-fail’ approach to evaluating κ-opioid antagonism as a treatment for anhedonia

    Authors: , , , , , , , , , , , , , , , , , , , - Nature Medicine 2020 cited by 229

  12. Assessing anhedonia in depression: Potentials and pitfalls

    Authors: , , , - Neuroscience & Biobehavioral Reviews 2016 cited by 580

  13. Reduced hedonic capacity in major depressive disorder: Evidence from a probabilistic reward task

    Authors: , , , , - Journal of Psychiatric Research 2008 cited by 797

  14. Dynamic Resting-State Functional Connectivity in Major Depression

    Authors: , , , , , , , , - Neuropsychopharmacology 2015 cited by 439

  15. Resting-state fMRI functional connectivity and mindfulness in clinical and non-clinical contexts: A review and synthesis

    Authors: , , - Neuroscience & Biobehavioral Reviews 2022 cited by 205

  16. Establishing moderators and biosignatures of antidepressant response in clinical care (EMBARC): Rationale and design

    Authors: , , , , , , , , , , , , , , , , , , , , , - Journal of Psychiatric Research 2016 cited by 296

  17. Reward processing dysfunction in major depression, bipolar disorder and schizophrenia

    Authors: , , - Current Opinion in Psychiatry 2014 cited by 756

  18. Reduced Reward Learning Predicts Outcome in Major Depressive Disorder

    Authors: , , , , , , , - Biological Psychiatry 2012 cited by 448

  19. Toward an objective characterization of an anhedonic phenotype: A signal-detection approach

    Authors: , , - Biological Psychiatry 2005 cited by 756

  20. Mechanisms of Memory Disruption in Depression

    Authors: , - Trends in Neurosciences 2018 cited by 261

  21. Evidence-based umbrella review of 162 peripheral biomarkers for major mental disorders

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Translational Psychiatry 2020 cited by 213

  22. Dysfunctional reward processing in depression

    Authors: , - Current Opinion in Psychology 2015 cited by 352

  23. Abnormalities in electroencephalographic microstates are state and trait markers of major depressive disorder

    Authors: , , , , , , , - Neuropsychopharmacology 2020 cited by 149

  24. Impact of the KCNQ2/3 Channel Opener Ezogabine on Reward Circuit Activity and Clinical Symptoms in Depression: Results From a Randomized Controlled Trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , - American Journal of Psychiatry 2021 cited by 82